Related Experiment Video
Updated: Jun 23, 2025

Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters
Published on: June 23, 2023
TSPO in pancreatic beta cells and its possible involvement in type 2 diabetes
Ghislaine Guillemain1, Lucie Khemtemourian2, Juliette Brehat3
1Sorbonne Université, Institut Hospitalo-Universitaire, INSERM UMR_S938, Institute of Cardiometabolism and Nutrition (ICAN), Centre de Recherche de St-Antoine (CRSA), 27 Rue de Chaligny, 75012, Paris, France.
Abstract:
Amyloidosis forms a large family of pathologies associated with amyloid deposit generated by the formation of amyloid fibrils or plaques. The amyloidogenic proteins and peptides involved in these processes are targeted against almost all organs. In brain they are associated with neurodegenerative disease, and the Translocator Protein (TSPO), overexpressed in these inflammatory conditions, is one of the target for the diagnostic. Moreover, TSPO ligands have been described as promising therapeutic drugs for neurodegenerative diseases. Type 2 diabetes, another amyloidosis, is due to a beta cell mass decrease that has been linked to hIAPP (human islet amyloid polypeptide) fibril formation, leading to the reduction of insulin production. In the present study, in a first approach, we link overexpression of TSPO and inflammation in potentially prediabetic patients. In a second approach, we observed that TSPO deficient rats have higher level of insulin secretion in basal conditions and more IAPP fibrils formation compared with wild type animals. In a third approach, we show that diabetogenic conditions also increase TSPO overexpression and IAPP fibril formation in rat beta pancreatic cell line (INS-1E). These data open the way for further studies in the field of type 2 diabetes treatment or prevention.
Insights
Translocator Protein (TSPO) is linked to inflammation and amyloidosis in type 2 diabetes. TSPO deficiency increases insulin secretion and human islet amyloid polypeptide (hIAPP) fibril formation, suggesting TSPO as a therapeutic target.
Area of Science:
- Biomedical Science
- Endocrinology
- Neuroscience
Background:
- Amyloidosis involves amyloid deposits, fibrils, or plaques, affecting various organs.
- In the brain, amyloidosis is linked to neurodegenerative diseases, with Translocator Protein (TSPO) overexpression indicating inflammation.
- Type 2 diabetes involves beta cell loss due to human islet amyloid polypeptide (hIAPP) fibril formation, reducing insulin production.
Purpose of the Study:
- To investigate the link between TSPO, inflammation, and type 2 diabetes.
- To explore the role of TSPO in hIAPP fibril formation and insulin secretion.
Main Methods:
- Correlating TSPO overexpression and inflammation in prediabetic patients.
- Comparing insulin secretion and hIAPP fibril formation in TSPO-deficient rats versus wild-type rats.
- Examining TSPO overexpression and hIAPP fibril formation in INS-1E rat beta cells under diabetogenic conditions.
Main Results:
- TSPO overexpression and inflammation were linked in potentially prediabetic patients.
- TSPO-deficient rats exhibited higher basal insulin secretion and increased hIAPP fibril formation.
- Diabetogenic conditions elevated TSPO expression and hIAPP fibril formation in rat beta cells.
Conclusions:
- TSPO is implicated in the inflammatory processes of type 2 diabetes.
- Modulating TSPO may offer a novel therapeutic strategy for type 2 diabetes treatment or prevention.
Related Concept Videos
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Cells and Secretions of the Pancreas
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational

